Vaccine News and Research

Latest Vaccine News and Research

World must be better prepared for potential pandemics

"In China an influenza virus never before seen in people had, as The Economist went to press, infected at least 82 and killed 17. Meanwhile a new type of coronavirus, the family that brought severe acute respiratory syndrome (SARS), is festering in the Middle East," an editorial in the magazine states.

23 Apr 2013

Experts call for better vaccine supply, logistics systems ahead of World Immunization Week

In recognition of World Immunization Week, which began April 21, the WHO "is calling on nations to help immunize more children against preventable diseases so more lives can be saved," VOA News reports, noting the U.N. health agency "estimates immunization saves the lives of two to three million children every year."

23 Apr 2013

Britain to 'stand together' with other stakeholders to eradicate polio

"[V]accinations play a huge part in deciding a country's long-term health," and "[t]he more healthy a population, the better able it is to contribute to and benefit from economic development," British Secretary of State for International Development Justine Greening writes in an Independent opinion piece.

23 Apr 2013

New collaboration to expand vaccine approaches for melanoma

Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.

23 Apr 2013

Advaxis to license its ADXS-HPV product candidate to FusionVax

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a Memorandum of Understanding (MoU) with FusionVax, Inc. ("FusionVax") setting forth the main terms under which Advaxis will, subject to the entry of a definitive agreement, exclusively license its lead clinical stage product candidate, ADXS-HPV, to FusionVax for Asia.

22 Apr 2013

National Foundation for Infectious Diseases to host 16th Annual Conference on Vaccine Research

The National Foundation for Infectious Diseases will host the 16th Annual Conference on Vaccine Research, April 22-24, 2013, at the Hyatt Regency Inner Harbor in Baltimore, MD.

22 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

Vaccine development expensive but worthy of investment from Congress

During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines, and the collaborative efforts of the [CDC], [the WHO], national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases.

22 Apr 2013

Research roundup: Community benefits and hospitals' tax-exempt status; Medicaid expansion could benefit people of color; Looking at changes for Medicare

The federal health law requires tax-exempt hospitals to assess and address the needs of the community in which they serve by the end of 2013.

20 Apr 2013

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

In a manuscript published today in Immunity, scientists at the Baylor Institute for Immunology Research (BIIR) and the Benaroya Research Institute at Virginia Mason report the results of a comparative study of the molecular immune responses to influenza and pneumococcal vaccines.

19 Apr 2013

Nature reports on efforts to vaccinate Nigeria's nomadic communities against polio

"A 25-year, $10 billion global effort has taken the number of polio cases from hundreds of thousands per year to just hundreds, but it is now struggling to stamp the virus out of its final strongholds in Pakistan, Afghanistan and Nigeria, where transmission has never been interrupted," Nature reports.

19 Apr 2013

SCCA pioneers new transplant procedures to reduce need for matching bone marrow donors

Patients from ethnic minority and mixed-racial backgrounds are less likely to receive a lifesaving bone marrow transplant than Caucasian patients with the same disease due to lack of matching donors, according to the National Marrow Donor Program.

19 Apr 2013

GBM brain cancer patient treated with DCVax-L celebrates 10th anniversary of cancer-free survival

Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that Brad Silver, an All American swimming and water polo athlete who was diagnosed with Glioblastoma multiforme brain cancer in late 2002, and was treated with DCVax-L in March of 2003, just celebrated the 10th anniversary of his continued cancer-free survival.

19 Apr 2013

Indian drug supplier cuts price of 5-in-1 childhood vaccine for GAVI Alliance; Groups highlight World Immunization Week

"The cost of immunizing children in developing countries with a five-in-one vaccine is set to fall after a deal by an Indian supplier to slash the price it charges the GAVI global vaccines group," Reuters reports.

19 Apr 2013

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.

19 Apr 2013

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

Sinovac Biotech Ltd., a leading provider of vaccines in China, announced today that Fengcai Zhu, Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, presented data regarding Sinovac's proprietary enterovirus 71 ("EV71") vaccine against hand, foot and mouth disease at the 13th Annual World Vaccine Congress & Expo, taking place from April 16-18, 2013, in Washington D.C.

19 Apr 2013

Global experts highlight strategies to immunize more children

In advance of World Immunization Week, global experts are highlighting strategies to further advance progress on the Global Vaccine Action Plan that was endorsed by the World Health Assembly, 2012.

19 Apr 2013

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

The bombs at the Boston Marathon were designed to maim and kill, and they did. Three people died within the first moments of the blast. More than a hundred and seventy people were injured. They had their limbs blown off, vital arteries severed, bones fractured, flesh torn open by shrapnel or scorched by the blasts' heat. Yet it now appears that every one of the wounded alive when rescuers reached them will survive.

19 Apr 2013

New assays are effective in managing patients with influenza virus infection

Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly.

18 Apr 2013

Two abstracts related to Advaxis' ADXS-HPV selected for poster presentation at ASCO meeting

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.

18 Apr 2013

Vaccine News and Research

Latest Vaccine News and Research

World must be better prepared for potential pandemics

Experts call for better vaccine supply, logistics systems ahead of World Immunization Week

Britain to 'stand together' with other stakeholders to eradicate polio

New collaboration to expand vaccine approaches for melanoma

Advaxis to license its ADXS-HPV product candidate to FusionVax

National Foundation for Infectious Diseases to host 16th Annual Conference on Vaccine Research

Edible malarial vaccine may work against other viral and bacterial infections

Vaccine development expensive but worthy of investment from Congress

Research roundup: Community benefits and hospitals' tax-exempt status; Medicaid expansion could benefit people of color; Looking at changes for Medicare

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

Nature reports on efforts to vaccinate Nigeria's nomadic communities against polio

SCCA pioneers new transplant procedures to reduce need for matching bone marrow donors

GBM brain cancer patient treated with DCVax-L celebrates 10th anniversary of cancer-free survival

Indian drug supplier cuts price of 5-in-1 childhood vaccine for GAVI Alliance; Groups highlight World Immunization Week

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

Global experts highlight strategies to immunize more children

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

New assays are effective in managing patients with influenza virus infection

Two abstracts related to Advaxis' ADXS-HPV selected for poster presentation at ASCO meeting

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in